Advanced search
Publication Cover
Cancer Biology & Therapy Volume 17, 2016 - Issue 5
Submit an article Journal homepage
1,366
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivo

Yanjun DiaoDepartment of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China;Public Health England Clinical Microbiology & Public Health Laboratory Cambridge, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, UK
,
Jiayun LiuDepartment of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China
,
Yueyun MaDepartment of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China
,
Mingquan SuDepartment of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China
,
Hongyi ZhangPublic Health England Clinical Microbiology & Public Health Laboratory Cambridge, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, UKCorrespondence[email protected] [email protected]
&
Xiaoke HaoDepartment of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, ChinaCorrespondence[email protected] [email protected]
Pages 498-506 | Received 09 Dec 2015, Accepted 14 Feb 2016, Published online: 13 Apr 2016

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lei Lyu, Lu-qi Huang, Tao Huang, Wei Xiang, Jing-dong Yuan & Chuan-hua Zhang. (2018) Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis. Drug Design, Development and Therapy 12, pages 743-756.
Read now

Articles from other publishers (17)

Yadollah Omidi, Jaleh Barar, Somayeh Vandghanooni, Morteza Eskandani & Hossein Omidian. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 103 139 .
Carlos David Cruz-Hernández, Griselda Rodríguez-Martínez, Sergio A. Cortés-Ramírez, Miguel Morales-Pacheco, Marian Cruz-Burgos, Alberto Losada-García, Juan Pablo Reyes-Grajeda, Imelda González-Ramírez, Vanessa González-Covarrubias, Ignacio Camacho-Arroyo, Marco Cerbón & Mauricio Rodríguez-Dorantes. (2022) Aptamers as Theragnostic Tools in Prostate Cancer. Biomolecules 12:8, pages 1056.
Crossref
Nuno Vale, Diana Duarte, Sara Silva, Ana Salomé Correia, Bárbara Costa, Maria João Gouveia & Abigail Ferreira. (2020) Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacological Research 162, pages 105231.
Crossref
Sol Min, Kichul Kim, Seockmo Ku, Jeong‐Yoon Park, Jeongmin Seo & Sangho Roh. (2020) Newly synthesized peptide, Ara‐27, exhibits significant improvement in cell‐penetrating ability compared to conventional peptides. Biotechnology Progress 36:5.
Crossref
Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Vahideh Zarrin, Sharareh Hosseinzadeh Kashani, Saied Bokaie, Masoud Najafi, Shima Tavakol, Reza Mohammadinejad, Noushin Nabavi, Chia-Ling Hsieh, Atefeh Zarepour, Ehsan Nazarzadeh Zare, Ali Zarrabi & Pooyan Makvandi. (2020) Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer. Bioengineering 7:3, pages 91.
Crossref
Krishna Baxi, Sujata Sawarkar, Munira Momin, Vainav Patel & Trinette Fernandes. (2020) Vaginal siRNA delivery: overview on novel delivery approaches. Drug Delivery and Translational Research 10:4, pages 962-974.
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. International Journal of Molecular Sciences 21:8, pages 2793.
Crossref
Jaehoon Lee, Mijin Kwon, Naeun Oh, Jaehyun Park, Sangkyu Park, Jeongmin Seo & Sangho Roh. (2020) Cell-Penetrating Peptides Enhance the Activity of Human Fibroblast Growth Factor 2 by Prolonging the Retention Time: A New Vision for Drug-Delivery Systems. International Journal of Molecular Sciences 21:2, pages 442.
Crossref
Ana Paula Dinis Ano Bom, Patrícia Cristina da Costa Neves, Carlos Eduardo Bonacossa de Almeida, Dilson Silva & Sotiris Missailidis. (2019) Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer. Pharmaceutics 11:12, pages 684.
Crossref
Weibin Li, Meng Zhao, Huihui Yan, Kaiyu Wang & XIaopeng lan. (2019) Aptamer Oligonucleotides as Potential Therapeutics in Hematologic Diseases. Mini-Reviews in Medicinal Chemistry 19:10, pages 788-795.
Crossref
Padmanaban Sivakumar, Sumin Kim, Han Chang Kang & Min Suk Shim. (2018) Targeted siRNA delivery using aptamer‐siRNA chimeras and aptamer‐conjugated nanoparticles. WIREs Nanomedicine and Nanobiotechnology 11:3.
Crossref
Fatemeh Araste, Khalil Abnous, Maryam Hashemi, Seyed Mohammad Taghdisi, Mohammad Ramezani & Mona Alibolandi. (2018) Peptide-based targeted therapeutics: Focus on cancer treatment. Journal of Controlled Release 292, pages 141-162.
Crossref
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar & Yadollah Omidi. (2018) Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective. Journal of Molecular Medicine 96:9, pages 885-902.
Crossref
Zimu Zhang, Zhi Yao & Rongxin Zhang. 2018. The Epigenetics of Autoimmunity. The Epigenetics of Autoimmunity 359 386 .
Ahad Mokhtarzadeh, Maryam Tabarzad, Javad Ranjbari, Miguel de la Guardia, Maryam Hejazi & Mohammad Ramezani. (2016) Aptamers as smart ligands for nano-carriers targeting. TrAC Trends in Analytical Chemistry 82, pages 316-327.
Crossref
Subash C. B. Gopinath, Thangavel Lakshmipriya, Yeng Chen, M. K. Md Arshad, Jesinda P. Kerishnan, A. R. Ruslinda, Yarub Al-Douri, C. H. Voon & Uda Hashim. (2016) Cell-targeting aptamers act as intracellular delivery vehicles. Applied Microbiology and Biotechnology 100:16, pages 6955-6969.
Crossref
Shanni Hong, Na Sun, Min Liu, Jine Wang & Renjun Pei. (2016) Building a chimera of aptamer–antisense oligonucleotide for silencing galectin-1 gene. RSC Advances 6:113, pages 112445-112450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.